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Increased polyamine concentrations play an important role in
the development of cancer at all stages, from initiation through
to maintenance of the transformed phenotype. One way cancer
cells accumulate increased concentrations of polyamines is
by increased uptake of preformed polyamines via their PTS
(polyamine transport system). The PTS is promiscuous and will
transportarangeofpolyamine-basedmolecules.Thereforeitmay
be that cytotoxic drugs could be attached to polyamine vectors
and targeted selectively to cancer cells by utilizing the PTS.
The aim of the present study was to investigate the potential
of Ant 4, a putrescine–anthracene conjugate, to target cytotoxic
agents to human cancer cells as a paradigm for a novel method
of selective drug delivery. Ant 4 induced cytotoxicity after only
24 h exposure. Apoptosis was the predominant type of cell death,
with mechanistic studies revealing that oxidative stress and DNA
damage may have a part to play. For the ﬁrst time, uptake of
Ant 4 via the PTS was demonstrated both directly and indirectly
in human cell lines. In addition, Ant 4 signiﬁcantly reduced
putrescine uptake, demonstrating that this conjugate not only
used the PTS, but also could successfully compete with its native
polyamine for uptake. However, the most interesting ﬁnding was
the intracellular depletion of the polyamine pools, providing an
additional mode of toxicity for Ant 4 and the possibility that
this molecule may act as a ‘double-edged sword’: preventing
cell growth by delivery of the toxic moiety and by depletion of
intracellular polyamine content.
Key words: apoptosis, cancer, DNA damage, drug conjugate,
leukaemia, polyamine.
INTRODUCTION
The development of a ‘magic bullet’ for cancer therapy would
revolutionizecurrenttreatment.Althoughsomeheadwayhasbeen
made, the majority of chemotherapeutic agents are limited by
their non-speciﬁc actions and side effects. As a result, the maxi-
mum therapeutic dose which can be given and, therefore, the
maximum anti-cancer effect these agents can exert is restricted.
This latter point is a particular disappointment, given that many
agents possess potent anti-cancer activity in vitro. Thus if
these agents could be delivered selectively to tumour cells,
the ‘holy grail’ of an effective anti-cancer drug with minimal
peripheraltoxicitywouldbeareality.Onepossibilityisthatdrugs
could be targeted to cancer cells via selective transport systems
such as the polyamine pathway.
The polyamines have a multitude of roles within the cell. Most
important, however, is that tight regulation of their intracellular
concentration is required for normal cell growth [1]. Indeed, it
is well known that increased polyamine concentrations play an
important role in the development of cancer at all stages from
initiation through to maintenance of the transformed phenotype
[2].Onewaycancercellsaccumulateincreasedintracellularpoly-
amine concentrations is by increased uptake of preformed
polyamines from the extracellular environment via their PTS
(polyamine transport system) [3].
In comparison with normal cells, it has been shown that trans-
formed cells accumulate exogenous polyamines at an enhanced
rate [4,5]. In vivo, radiolabelled putrescine accumulates in brain
tumours at a rate 30-fold greater than the surrounding normal
brain parenchyma [6]. In addition, the human promyelocytic
leukaemia cell line HL-60 has an afﬁnity for putrescence,
spermidine and spermine between 10- and 200-fold greater
than normal human PMNs (polymorphonuclear leucocytes) [7].
Furthermore, uptake of putrescine is 3.6-fold greater in the HL-
60 cell line in comparison with normal PMNs [7]. The impor-
tance of the PTS in cancer cells is further underlined when
in PTS-deﬁcient cell models, the curative effect of DFMO
(α-diﬂuoromethylornithine), a polyamine synthesis inhibitor, is
increased due to the PTS-deﬁcient cell model being unable to
utilize extracellular polyamines to compensate for the loss of
biosynthesis [8]. Most importantly, however, is the promiscuous
nature of the PTS, with it being unable to differentiate between
naturalpolyaminesandarangeofstructuralanalogues[9].Indeed,
it has been shown that the PTS can tolerate a wide range of
additions to the basic polyamine molecule. Interestingly, speciﬁc
depletion of one polyamine does not result in selective uptake of
that depleted polyamine [10].
By using these features of the PTS, it has been proposed that
the transport system can be exploited to deliver cytotoxic drugs
to cancer cells. With cancer cells demonstrating high transport
activity and an increased demand for polyamines, the attachment
of cytotoxic compounds to polyamines would allow speciﬁc
targeting of cancer cells [11]. The polyamine can be attached
to the toxin to provide a vector for delivery through the PTS and,
indoingso,reducethetoxiceffectonnormalcellsassociatedwith
conventional chemotherapy and therefore decrease peripheral
toxicity. With this in mind, a series of compounds combining
the DNA-intercalating agent, anthracene, with a polyamine side
chain were synthesized [9].
The aim of the present study was to investigate the potential of
Ant 4, a putrescine–anthracene conjugate, to target anthracene to
human cancer cells as a paradigm for a novel method of selective
Abbreviationsused:Ant4,aputrescine–anthraceneconjugate;AZP,azirdine–putrescineconjugate;CHO, Chinese-hamsterovary;DAPI, 4 ,6-diamidino-
2-phenylindole;DFMO,α-diﬂuoromethylornithine;FBS,foetalbovineserum;HDAC,histonedeacetylase;MTT,3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-
tetrazolium bromide; ODC, ornithine decarboxylase; OPA, o-phthalaldehyde; PCA, perchloric acid; PMN, polymorphonuclear leucocyte; PTS, polyamine
transport system; ROS, reactive oxygen species; SAHA, suberoylanilide hydroxamic acid.
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drug delivery using the human leukaemia HL-60 cell line as an in
vitro model system.
MATERIALS AND METHODS
Materials
RPMI 1640 growth medium, penicillin and streptomycin
were from Life Technologies. Acrodisc 0.2 μM pore syringe
ﬁlters, BSA, copper sulfate, cytoﬁlter cards, dansyl chloride
[(CH3)2NC10H6SO2Cl], DAPI (4
 ,6-diamidino-2-phenylindole),
DMSO, disodium hydrogen orthophosphate, ethanol, EDTA,
Folin and Ciocalteau’s phenol reagent, formaldehyde (38%
w/v), glass coverslips (22 mm
2) thickness number 1, glutathione
(reduced form), glycerol, propan-2-ol, slides (SuperFrost 1 mm),
70% (v/v) PCA (perchloric acid), sodium carbonate, sodium
chloride, sodium hydroxide and sodium potassium tartrate were
obtained from the Sigma Chemical Company. Goldstar scintil-
lation ﬂuid was obtained from Canberra Packard.
14C-labelled
polyamines were obtained from Amersham International.
All cell-culture plastics which included cuvettes, cryovials
(1.8 ml), 96-well microtitre plates, 10 ml sterile syringes,
19-gauge needles, cell-culture ﬂasks (25 cm
2 and 75 cm
2), cell-
culture plates (3.5 cm, 5 cm and 10 cm), pipettes (digital P20,
P200, P1000 and P5000), universal containers (15 ml, 30 ml and
50 ml), stripette pump and sterile stripettes (5 ml, 10 ml
and 25 ml) were obtained from Nunc (Nalge Nunc International).
FBS (foetal bovine serum) was from PAA Laboratories. Trypan
Blue and MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-
tetrazolium bromide] were obtained from the Sigma Chemical
Company. Acetonitrile (HPLC Grade) was obtained from Refer
Scientiﬁc. HA nitrocellulose ﬁlter (pore size, 0.45 μm) was from
Millipore. HPLC vials and caps were obtained from Anachem.
OPA (o-phthalaldehyde) was from Fisher Scientiﬁc.
Ant 4 was synthesized by Professor Otto Phanstiel’s group at
the University of Central Florida, Orlando, FL, U.S.A. Synthesis
of this compound has been previously described [12].
Cell-culture methods
HL-60 human promyelogenous leukaemic cells were grown in
suspension inRPMI 1640medium supplementedwith 10% (v/v)
FBS, 50 units/ml penicillin and 50 μg/ml streptomycin (termed
RFC10).Thecellsweregrownat37◦Cinahumidiﬁedatmosphere
ﬂushed with 5% CO2. Owing to the susceptibility of HL-60 cells
to differentiate spontaneously beyond the promyelocytic stage
with increasing time in culture, cells were routinely subcultured
every 2–3 days, reseeded at a ratio of 1:6 and kept for a maximum
of 6 weeks before being replaced with freshly recovered stocks.
For experiments, cells were seeded at 6.8×10
4 cells/ml and
grown for 48 h prior to treatment.
Measurement of cytotoxicity
Cytotoxicity was measured using the MTT assay, based on the
method of Denziot and Lang [13], from the original method
described by Mosmann [14]. In summary, HL-60 cells were
plated on to 96-well plates and grown for 48 h, after which time
cells were treated with various concentrations of drug. After 48 h
exposure, MTT was added to the plates at a concentration of
5 mg/ml as a sterile solution dissolved in complete PBS. Plates
were then left for 4 h in a humidiﬁed atmosphere of 5% CO2 at
37◦C. Metabolism of MTT by actively respiring cells produces
an insoluble formazan salt which was then dissolved using 100%
DMSO. Absorbance values were measured at wavelengths of
540 and 690 nm and expressed as a percentage of the untreated
controls.
Determination of conjugate uptake
To determine whether Ant 4 was gaining entry into the cell,
deconvolution microscopy was used. In summary, cells were
seeded at the appropriate density on 3.5-cm plates and grown
for 48 h. After 48 h, cells were incubated with vehicle (0.9%
saline) or Ant 4 for 30 min before being harvested. Cells were
centrifuged for 5 min at 2800 gav. The supernatant was discarded
and the cells were washed twice in 1 ml of complete PBS. Then,
100 μl of cells were ﬁxed on to a microscope slide before being
coatedwith150 μlofpoly-lysine(1 mg/ml)andcoverdwithadry
coverslip. Slides were then incubated for 1 h at room temperature
(20◦C). After this time, slides were viewed using a DeltaVision
Core machine with an excitation wavelength of 364 nm and an
emission wavelength of 417 nm.
Conjugate activity on cell growth
HL-60 cell growth was determined using the Trypan Blue
exclusion assay. To determine cell number, 100 μlo fc e l ls u s -
pension was mixed with 900 μl of Trypan Blue and cells were
counted using an improved Neubauer haemocytometer. This
methodalsoallowedviabilitytobedetermined,sinceTrypanBlue
penetrates non-viable cells, staining them blue. A modiﬁcation of
the method described by Lowry et al. [15] was used to determine
total cellular protein. Samples were quantiﬁed against standards,
prepared from a stock solution of 500 μg/ml BSA, to provide a
range of standards from 0 to 250 μg/ml BSA.
Determination of intracellular polyamine concentrations
Aftertheappropriatetimeinterval,HL-60cellswereharvestedby
theremovalofcellsandmediumtoasterile15 mlcentrifugetube.
To ensure that all cells had been removed from the plate, the plate
was rinsed with an equal volume of RFC10 which was added to
the tube. Next, the cell suspension was centrifuged at 2800 gav for
5 min. The supernatant was discarded and the pellet was washed
twice in 1 ml of complete PBS before being transferred to a clean
microtube. The cell suspension was centrifuged again at 7500 gav
for 5 min and the supernatant discarded before resuspending the
pellet in 300 μl of 0.2 M PCA. This was placed on ice for 30 min
in order to extract the acid-soluble fraction. After this time each
tubewascentrifugedat7500 gav for5 minandthesupernatantwas
removed to a clean Eppendorf tube. This was stored at −20◦C
until analysis by HPLC. The method of HPLC used was that
of pre-column dansylation. Samples were dansylated at 25◦C
overnight, extracted in toluene, blown to dryness in a nitrogen
stream, and then reconstituted in 200 μl of acetonitrile. Samples
were analysed by reverse-phase HPLC on a Hichrom RPB 5 μm
column using a gradient of 100% acetonitrile to 40:60 (v/v)
acetonitrile/water.
Determination of polyamine uptake
Polyamine uptake was determined using radiolabelled poly-
amines.Insummary,cellswereseededat6.8×10
4/mlintriplicate
on 24-well plates for 48 h. After this time, cells were incubated
with 5 nCi/ml of the appropriate
14C-labelled polyamine with
or without 15 μM Ant 4 for 10, 20, 30 and 60 min. After the
appropriate exposure, the cell suspension was removed, placed in
amicrotubeandcentrifugedfor5 minat2800 gav.Thesupernatant
was discarded and the cells were washed in 1 ml of complete PBS
before being centrifuged for 4 min at 2800 gav. The supernatant
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was again discarded before resuspending the cells in 300 μlo f
0.2 M PCA and storing on ice for 30 min in order to allow acid
extractionandproteinprecipitation.Afterthistime,thecellswere
centrifuged for 5 min at 2800 gav and the acid-soluble fraction
was removed to a clean microtube. Then, 300 μl of 0.3 M NaOH
was added to the remaining pellet which was left to dissolve
overnight at 37◦C before protein content was measured using
the Lowry method [15]. To analyse the uptake of polyamine,
50 μl of the acid-soluble fraction was added to a scintillation
vial containing 4 ml of scintillation ﬂuid. Finally the amount of
radioactive polyamine taken up by cells was counted using a
Canberra Packard 1900A Scintillation spectrophotometer with a
protocol for
14C. Samples were counted for 10 min or 10000
counts, with a 2% σ error.
Determination of glutathione content
Intracellular glutathione was extracted in 0.2 M PCA and stored
at −20◦C until measurement. The method used was based on
the method of Cohn and Lyle [15a], as modiﬁed by Hissin and
Hilf [15b]. In summary, a range of standards (0, 10, 25, 50, 75
and 100 μM) were prepared from a 1 mM stock of reduced
glutathione dissolved in deionized water. Sample or standard
(25 μl)wasthenaddedto2.3 mlofglutathionebuffer,followedby
100 μlofOPAsolution(1 mg/mlinmethanol)andleftfor15 min.
After this time, each tube was decanted into a ﬂuorimetric cuvette
and read in turn using a PerkinElmer LS-50B luminescence
spectrophotometer set at an excitation wavelength of 350 nm,
with a slit width of 5 mm and emission wavelength of 420 nm.
A standard curve was plotted and this was used to determine the
amount of reduced glutathione (in nmol) present in the samples.
Determination of DNA damage
DNA damage was detected using the Comet assay. The method
used was based on the method of Singh et al. [16]. Fully frosted
slides were coated with 100 μlo f1% standard agarose in PBS
andcoveredwithaglasscoverslip.Next,theslideswereincubated
at 4◦C for 5 min to allow the agarose to solidify. Next, cell
suspensions were centrifuged at 2800 gav for 5 min at 4◦C. The
supernatantwasdiscardedandthepelletwaswashedtwicein1 ml
ofPBS.Thesupernatantwasthenremovedandthecellsweredis-
persedinthesmallvolumeofmediumremaininginthetube.Next,
85 μlof1%LMP(lowmeltingpoint)agaroseinPBSat37◦Cwas
added and immediately pipetted on to a frosted slide. The agarose
was allowed to set for 10 min at 4◦C. After solidiﬁcation, the
slides were incubated in lysis solution [2.5 M NaCl, 10 mM Tris,
100 mM EDTA (NaOH to pH 10) with 1% (v/v) Triton X-100]
for 1 h at 4◦C to remove cellular protein. This leaves the DNA
as distinct nucleoids. After lysis, the slides were washed three
times in endonuclease III buffer [40 mM Hepes/KOH, 0.1 M
KCl, 0.5 mM EDTA and 0.2 mg/ml BSA (pH 8.0)]. After rinsing,
the slides were blotted dry and incubated with endonuclease III
(1 μg/ml) for 45 min. After this time, slides were placed side-by-
side in a horizontal electrophoresis chamber. The chamber was
ﬁlledwithrunningbuffertoapprox.2 mmabovetheagaroselayer,
andtheslidesweresubjectedtoelectrophoresisat25 Vfor30 min
at 4◦C. Following electrophoresis, the slides were rinsed three
times for 5 min in neutralizing buffer [0.4 M Tris/HCl (pH 7.5)]
and allowed to dry. Slides were then stained with DAPI (5 μg/ml)
justbeforeexaminationunderanOlympusBX40microscopewith
an Olympus U-RFL-T ﬂuorescent burner and DAPI ﬁlter.
Detection of apoptosis
In order to assess the changes in morphology associated with
apoptosis, the nuclear chromatin of the cells was stained with the
ﬂuorigenic compound DAPI. In summary, cells were ﬁxed in
0.4% formaldehyde before being centrifuged (200 g for 5 min)
on to glass slides and stained with DAPI. The morphology of
the nuclei of the cells was then observed using a ﬂuorescence
microscope, which was an Olympus BX40 microscope with an
Olympus U-RFL-T ﬂuorescent burner and DAPI ﬁlter. Nuclei
wereconsideredtohaveanormalphenotypebytheirmorediffuse
and grey staining. Apoptotic nuclei were identiﬁed by the fact
that they were brightly stained due to fragments of DNA that had
DAPI stain bound. For quantiﬁcation, a blinded observer counted
100 cells ﬁve times from non-overlapping views.
Flow cytometry
A cell-cycle proﬁle was obtained and apoptosis detected by ﬂow
cytometry. In summary, HL-60 cells were grown on 10-cm plates
for 48 h before treatment with 15 μM Ant 4 or vehicle for 48 h.
After this time, cells were harvested and centrifuged for 5 min
at 800 gav. The medium was then discarded, and the cell pellet
was resuspended in the small volume of medium remaining in the
tube. Thecells were then resuspendedin 1 ml of Dulbecco’s PBS,
transferred to microtubes and centrifuged at 800 gav for 5 min.
The supernatant was again discarded, and the pellet was again
resuspended in the small volume remaining by knocking. Next,
cells were suspended in 1 ml of ice-cold 70% (v/v) ethanol
in deionized water and stored overnight at −20◦C to allow
quantiﬁcation of sub-G1 cells. Cells were then resuspended in
1 ml of staining buffer (50 μg/ml propidium iodide, 50 μg/ml
ribonuclease A and 0.1% Triton X-100 in PBS), before being
incubated at room temperature in the absence of light for 20 min.
Samples were then analysed by ﬂow cytometry using a Coulter
Flow Cytometer until sufﬁcient events (>10000) were obtained.
Statistical analysis
Statistical analysis was performed using GraphPad Prism 4.01.
All values shown are means+ −S.E.M. with each experiment
performed independently a minimum of three times with
replicates (unless otherwise stated).
RESULTS
TherangeofconcentrationsforAnt4andthetimeexposureswere
based on previously published work on this drug [9]. Ant 4 was
found to be cytotoxic to the HL-60 cell line, demonstrating dose-
dependent cytotoxicity (Figure 1), with a signiﬁcant cytotoxic
response at concentrations of 15 μM and above (P<0.01).
The IC50 value, at which 50% inhibition of cell growth was
observed, was calculated to be 20 μM after 48 h exposure.
Multiple studies from our laboratory have shown that IC50 values
calculated from MTT curves give an overestimate of the value
(F.R. Saunders and H.M. Wallace, unpublished work). Therefore
in order to examine the response to Ant 4 over time in greater
detail, a concentration of 15 μM was chosen (∼IC30 value). At
thisconcentration,inhibitionofgrowthwasobservedbydecreases
in both cell number (Figure 2) and protein content (result not
shown). Cytotoxic effects were observed after 24 h exposure to
Ant 4. Despite the low cell numbers at longer times, cell viability
remained high (86.5%), a feature common to apoptotic, rather
than necrotic, cell death [17].
Astheanthraceneconjugatescontainpolyamine-likemolecules
they could be considered similar to the polyamine analogues;
however, it is not known whether these conjugates affect the
polyamine content of cells. One of the ways that polyamine
analoguesinduceapoptosisisbycausingdepletionofintracellular
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Figure 1 Cytotoxicity of Ant 4 and the effect of DFMO on the cytotoxicity of
Ant 4 in HL-60 cell line
HL-60 cells were grown in RFC10 and seeded at 6.8×104 cells/ml in 96-well round-bottomed
microtitre plates and grown for 48h either with () or without () 1mM DFMO. After this
time, both pre-treated and untreated cells were exposed to increasing concentrations of Ant 4
for 48h. For the DFMO pre-treated cells, results shown are the means+ −S.E.M. (n=3), with
three replicates per experiment. For the control, i.e. no DFMO pre-treatment, results shown
are the means+ −S.E.M. (n=8); three with six replicates per experiment and ﬁve with three
replicates per experiment. Results were analysed statistically using ANOVA with Bonferroni’s
multiple comparison post-hoc test (*P <0.05).
Figure 2 HL-60 viable cell number in the presence of Ant 4
HL-60 cells were seeded at 6.8×104 cells/ml in 3.5-cm plates and grown for up to 144h.
After 48h, cells were treated with vehicle ()o r1 5μMA n t4( ). Duplicate plates were
harvested at 0h and then every 24h. Viable cell number and cell viability were determined
by Trypan Blue exclusion and microscopy. Protein content was determined uising the Lowry
assay. Results are the means+ −S.E.M. (n=4) with two replicates per experiment. Results
were analysed statistically using ANOVA with Bonferroni’s multiple comparison post-hoc test
(*P <0.01; **P < 0.001).
polyamine pools [17]. Therefore to determine whether Ant 4
was having additional analogue-type actions, the intracellular
polyamine concentrations in response to Ant 4 treatment were
measured over time.
Compared with the controls, HL-60 total polyamine content
(Figure3a)decreasedsigniﬁcantlyby53.8%at48 h(P<0.001),
50% at 72 h (P<0.05) and 68.7% at 96 h (P<0.01) after
addition of Ant 4. This was predominantly made up by decreases
in spermidine content (Figure 3b). Compared with the controls,
decreases in spermidine were 81.9% at 48 h (P<0.001), 74.0%
at 72 h (P<0.01) and 76.3% at 96 h (P<0.05) after addition of
Ant 4. Spermidine was also lower 24 h after addition of Ant 4,
but this was compensated by an increase in the concentration
Figure 3 (a) Total polyamine content in response to Ant 4 treatment;
(b) spermidine content in response to Ant 4 treatment; and (c) spermine
content in response to Ant 4 treatment
HL-60 cells were seeded at 6.8×104 cells/ml on 3.5-cm plates and grown for up to 144h.
After 48h growth, plates were exposed to vehicle (open bars) or 15 μM Ant 4 (closed bars).
Plates were harvested at 0h and then every 24h, with the polyamine fraction extracted in
0.2 M PCA and stored at −20◦C until its measurement. Samples were then dansylated and the
polyamine content determined by HPLC. Results shown are the means+ −S.E.M. (n=3) with
tworeplicatesperexperiment.ResultswereanalysedstatisticallyusingANOVAwithBonferroni’s
multiple comparison post-hoc test (*P <0.05; **P <0.01; ***P <0.001).
of spermine relative to the control. Compared with the controls,
spermine content was signiﬁcantly depleted 96 h after addition
of Ant 4 (P<0.05) (Figure 3c). Consistent with published [17]
and unpublished observations (H.M. Wallace, unpublished work)
fromourlaboratory,theintracellularpolyamineconcentrationsof
the controls decreased with increasing time in culture.
In the absence of a speciﬁc inhibitor of transport, several
approaches were used to determine whether Ant 4 utilized
the PTS. DFMO is a suicide inhibitor of ODC (ornithine
decarboxylase), the ﬁrst and rate-limiting enzyme in polyamine
synthesis. Treatment of HL-60 cells with DFMO has been shown
toresultinincreaseduptakeofpreformedpolyaminesviathePTS
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Figure 4 Deconvolution microscopy of (a) untreated HL-60 cells, (b) Ant 4-treated HL-60 cells and (c) DFMO- and Ant 4-treated HL-60 cells
HL-60 cells were seeded at 6.8×104 cells/ml on 3.5-cm plates and grown for 48 h with (c) and without (a and b) 5 mM DFMO pre-treatment. Following this, cells were left untreated (a) or treated
(b and c) with 15μM Ant 4 for 30min. After this time, cells were harvested and examined by deconvolution microscopy. Ant 4 localization is shown by the ﬂuorescent purple colour. The experiment
was repeated (n=3) with no replicates. Scale bar, 20μm.
[7]. HL-60 cells were pre-treated with 1 mM DFMO to increase
uptake before exposure to Ant 4. DFMO pre-treatment had a
signiﬁcant effect on the cytotoxicity of Ant 4 from concentrations
of 15 μM and above (P<0.05) in comparison with the control
(no DFMO pre-treatment). The IC50 value was decreased from
20.0 μM to 14.6 μM in the DFMO-treated cells (Figure 1),
suggesting increased uptake.
In addition to inhibition of topoisomerase II, the anthracene
component of Ant 4 has been shown to ﬂuoresce with a
wavelength maximum near 364 nm and emission maximum near
417 nm [12]. As such, the ﬂuorescent properties of Ant 4 can be
used to track its cellular localization. Therefore to see whether
the decrease in the IC50 value was due to increased uptake
of the conjugate and not due to synergy of DFMO and Ant 4,
deconvolution microscopy was used to see whether Ant 4 gained
entry to the HL-60 cells. Ant 4 was shown to localize within HL-
60 cells (Figure 4b) after 30 min exposure in comparison with the
untreated controls (Figure 4a). Furthermore, HL-60 cells grown
for 48 h in 5 mM DFMO prior to Ant 4 exposure demonstrated
greater accumulation of Ant 4 (Figure 4c) in comparison with
cells treated with Ant 4 only (Figure 4b).
To provide further evidence that Ant 4 utilized the PTS in
the HL-60 cell line, uptake studies were conducted. Uptake
of [
14C]putrescine was signiﬁcantly reduced by Ant 4 at 10
(P<0.0.001), 20 (P<0.001), 30 (P<0.001) and 60 (P<0.001)
min (Figure 5). This result suggests that Ant 4 successfully
competes with putrescine for the PTS in the HL-60 cell line.
Furthermore, Ant 4 had no inhibitory effect on spermidine or
spermine uptake (results not shown), suggesting that in the HL-
60 cell line, different transporters exist for the transport of the
individual polyamines.
With induction of apoptosis, the favoured cell death pathway
for any effective chemotherapeutic drug, the type of cell death
induced by Ant 4 was determined by a number of different
methods. DAPI staining of the cellular chromatin showed there
to be signiﬁcant induction of apoptosis (P<0.001) 48 h after
exposure to Ant 4, with 72.6% of cells displaying characteristic
morphological features of this type of cell death (Table 1).
This was in comparison with the controls where 3.1% of cells
displayed characteristic morphological features of apoptosis.
Analysis of the cell cycle (Table 2) also showed a statistically
signiﬁcant (P<0.05) increase in the apoptotic population (also
known as G0 or sub-G1). The G0 population was found to be
43.3% in the Ant 4-treated cells. This was in comparison with
the controls where it was found to be 12.4%.
Table 1 Apoptosis in response to Ant 4 treatment
HL-60 cells were seeded at 6.8×104 cells/ml in 3.5-cm plates and grown for 48h. After 48h,
cellsweretreatedwithvehicleor15 μMAnt4for48h.Afterthistimeplateswereharvested,and
after their preservation in 0.4% formaldehyde, cells were cytospun on to glass slides, stained
withDAPIandanalysedbyﬂuorescencemicroscopytoallowtheidentiﬁcationofapoptoticcells.
Theresultsshowtheviablecellnumber(×10−6)andthepercentageofapoptoticcells.Values
are the means+ −S.E.M. (n=3) with two replicates per experiment. Results were analysed
statistically using a paired Student’s t test (*P <0.05; **P <0.0001).
Treatment Viable cell number (×10−6) Apoptosis (percentage of the total cells counted)
Control 3.70+ −0.9 3.1+ −0.3
Ant 4 0.5+ −0.1* 72.6+ −4.1**
Figure 5 Putrescine uptake in response to Ant 4
HL-60 cells were seeded at 6.8×104 cells/ml on 24-well plates for 48h. After this time,
cells were incubated with [14C]putrescine for 10, 20, 30 and 60min with () or without
()1 5μM Ant 4. Plates were harvested at the appropriate timepoint and the polyamine
fraction extracted in 0.2 M PCA. Samples were then analysed using a Canberra Packard 1900A
scintillation spectrophotometer for 10min or 10000 counts, with a 2% error. Results shown
are the means+ −S.E.M. (n=3) with three replicates per experiment. Results were analysed
statistically using ANOVA with Bonferroni’s multiple comparison post-hoc test (*P <0.001).
In order to provide a possible explanation for the mechanism
of cell death, the glutathione content of the cells and the DNA
damage was measured after exposure to Ant 4.
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Table 2 Cell-cycle distribution in response to Ant 4 treatment
HL-60 cell were seeded at 6.8×104 cells/ml and grown for 48 h prior to treatment with vehicle
or 15μM Ant 4 for 48h. This Table details the percentage of cells from the total measured by
ﬂow cytometry that were classiﬁed in G0. The remaining phase of the cell cycle was adjusted
to 100%, and their distribution adjusted to a percentage of the total. The Table shows the
percentage distribution of three experiments (n=3) with one replicate per experiment. Data
were analysed statistically using a paired Student’s t test (*P <0.05).
Relative percentage of cells in each phase
Treatment G0 G1 SG 2/M
Control 12.4+ −0.4 22.6+ −6.5 38.5+ −1.6 26.5+ −2.6
Treated 43.3+ −3.9* 10.6+ −0.4 26.2+ −2.0 19.2+ −1.2
Figure 6 Glutathione content in response to Ant 4 treatment
HL-60 cells were seeded at 6.8×104 cells/ml in 3.5-cm plates and grown for up to 144h.
After 48h, cells were treated with vehicle (open bars) or 15μM Ant 4 (closed bars). Duplicate
plates were then harvested every 24h. Glutathione was extracted in 0.2 M PCA and stored
at −20◦C until its measurement. Results shown are the means+ −S.E.M. (n=3) with two
replicates per experiment. Results were analysed statistically using ANOVA with Bonferroni’s
multiple comparison post-hoc test (*P <0.05; **P <0.001).
In response to Ant 4 treatment, HL-60 cells showed a hugely
signiﬁcant decrease in glutathione content compared with the
controls at each 24 h time point after addition of Ant 4 (Figure 6).
These decreases were 70.6% at 24 h (P<0.001), 65.8% at
48 h (P<0.05), 60.0% at 72 h (P<0.05) and 80.1% at 96 h
(P<0.05). Furthermore, after 48 h exposure to Ant 4 there
was over a 3-fold increase in the DNA damage compared with
the controls (P< 0.01) (results not shown). Consistent with ob-
servations in our laboratory (A.V. Fraser and H.M. Wallace,
unpublished work), the glutathione content of the controls
decreased with increasing time in culture.
DISCUSSION
To date, the cytotoxicity of Ant 4 has been established in
CHO (Chinese-hamster ovary) cells [11,12,18], L1210 murine
leukaemia cells [11,12,18,19], B16 murine melanoma cells [19]
and the human cervical cancer cell line, HeLa [19]. We found
the HL-60 cell line to display dose-dependent cytotoxicity. The
requirementoflowamountsofAnt4tobringaboutthesechanges,
and the short time exposure, compares favourably with the
doses and exposure times used in the previously mentioned
in vitro studies.
In an effort to show that Ant 4 utilized the PTS to gain
entry into the cell, we compared the cytotoxicity of Ant 4
in untreated and DFMO-treated cells respectively. DFMO is a
suicide inhibitor of ODC, the ﬁrst and rate-limiting enzyme in
polyamine synthesis, and it has been shown that treatment of
HL-60 cells with DFMO results in depletion of intracellular
polyamines which is compensated for by increased active uptake
ofpreformedpolyaminesviathePTSofthecell[7].Asithasbeen
demonstrated with the anthracene conjugates that cytotoxicity is
directly related to cellular import [9,11], we used the increased
polyamineuptakeinducedbyDFMOandthesubsequentincrease
in cytotoxicity as indirect evidence for Ant 4 using the PTS to
gain entry into the cell. In addition, two further observations
support our hypothesis that Ant 4 is taken up by the PTS. First,
deconvolution microscopy demonstrated that DFMO resulted in
increased uptake of Ant 4 in comparison with cells treated with
Ant 4 only. This is the ﬁrst time increased cytotoxicity has been
directly related to increased uptake in human cell lines with these
conjugates,havingonlypreviouslybeendemonstratedusingCHO
cells [9,11]. Secondly, Ant 4 signiﬁcantly reduced the uptake of
putrescine, demonstrating that this conjugate not only used the
PTS, but that it could also successfully compete with its native
polyamine for uptake. Interestingly, spermidine and spermine did
not compete with Ant 4 for uptake, suggesting that more than one
transporter exists in the HL-60 cell line.
However, utilization of the PTS by Ant 4 goes against other
ﬁndings in the literature. Ant 4 has been shown to be no more
cytotoxic in DFMO-treated L1210 murine leukaemia cells when
compared with non-DFMO treated cells [12]. Work conducted on
a CHO and a PTS-deﬁcient CHO (MG-CHO) cell line has also
shown no difference in the cytotoxicity of Ant 4 [9,12]. However,
this can be explained by different PTS existing in different cell
types. In mammalian cells it has been shown that some
celltypeshaveasinglecarrierforallthreepolyamines.Thisisthe
case for L1210 murine leukaemia cells [20]; however, most cell
types appear to have two classes of carrier: one with a preference
for putrescine, and one for spermidine and spermine [1,10]. Work
conducted by others suggests this is the case for the HL-60 cell
line [7]. Indeed, two transporters existing in the HL-60 cell line
would support our ﬁnding that Ant 4 cannot inhibit the uptake
of spermidine and spermine. Furthermore, multiple transporters
are thought to exist in CHO cells [21]. Therefore it is likely that
different vectors work better on different cell types. For example,
an AZP(azirdine–putrescine) conjugatehasbeenshownto utilize
the PTS in the human prostate, PC3, cell line. This was shown
by demonstrating an 8.6-fold increase in its cytotoxicity and a
3.7-fold increase in the intracellular accumulation of AZP with
DFMO pre-treatment [22].
An important point to address with respect to DFMO-induced
polyamine depletion is that it has been shown to decrease
intracellular concentrations of calcium resulting in increased
membranepermeabilityinthenormalintestinalcelllineIE-6[23].
Therefore it could be argued that the increased absorption of Ant
4 we observed was due to an increase in membrane permeability
andnotincreasedtransport.However,intheHL-60cellline,ithas
been shown that polyamine depletion with DFMO has no effect
on calcium homoeostasis [24]. Therefore if DFMO is causing
increased membrane permeability in the HL-60 cell line, it is not
via alterations in intracellular calcium concentrations. As such,
we believe that the increased uptake of Ant 4 observed is due to
increased transport.
Another novel ﬁnding was the effect of these molecules on
polyamine metabolism. Indeed, it seems that these molecules
mayhaveanadditionalmodeoftoxicitybydepletingintracellular
polyamines, an event associated with induction of apoptosis via
the activation of p53 [25]. The depletion of spermidine is partic-
ularly interesting, given its importance in the post-translational
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modiﬁcation of eIF5A (eukaryotic initiation factor 5A), a
ubiquitous protein essential for cell growth [26].
However,whyshouldthesemoleculesbehavingsuchaneffect?
Onepossibilityischainelongationofthepolyamine.Forexample,
the putrescine part of Ant 4 may allow it to act as a substrate
for spermidine synthase resulting in chain elongation and the
formation of Ant 4,3. Bergeron et al. [27] observed this type of
chain extension event in vitro with N
1-substituted spermidine.
The formation of Ant 4,3 would result in the consumption of the
free aminopropyl units available and therefore hinder spermidine
synthesis resulting in a decreased intracellular concentration of
spermidine. However, analysis of our HPLC traces revealed no
evidence of any larger Ant 4 derivatives.
Another possible explanation is, given that these molecules
are polyamine-like, one could consider them synonymous with
the polyamine analogues, and as such, may have analogue-type
actions.WiththetopoisomeraseIIinhibitoryeffectsofanthracene
already established [28], this observation allows one to specu-
late onthepossibility ofa‘double-edgedsword’ effect.Therefore
we postulate that Ant 4 may be recognized by the cell as
a polyamine and induce their breakdown; however, like the
analogues,Ant4willbesufﬁcientlydifferentsoasnottofunction
as a polyamine in cells. With the effect of these molecules on the
enzymesinpolyaminemetabolismunknown,thisisaninteresting
avenue for future work.
Furthermore, with intracellular polyamines preferentially
binding to anionic DNA [1], polyamine depletion by Ant 4
would be desirable as this would allow Ant 4 to be targeted
to topoisomerase II, which is inhibited by anthracene. Indeed,
the inert nature of anthracene means the point charges on the
putrescine vector are not disturbed, thus allowing it to behave as a
native polyamine and therefore making it an ideal DNA-targeting
vector. Such a DNA-targeting effect is supported by work
conducted on the second-generation HDAC (histone deacetylase)
inhibitor SAHA (suberoylanilide hydroxamic acid; trade name,
Vorinostat) by Patrick Woster’s group [29]. In some cancers,
hypoacetylation of histones due to overactive HDAC results in
the underexpression of growth regulatory factors such as p21
Waf1.
Woster’s group attached SAHA to a number of polyamine vectors
toincreaseitsafﬁnityforchromatinanddemonstratedanincrease
in the expression of p21
Waf1 in comparison with SAHA alone
[29]. In addition, they also demonstrated that one of these SAHA
conjugates utilized the PTS for uptake [29].
For these anthracene conjugates many studies have looked at
their ability to interact with the PTS, but have not looked in any
detail at their effect on cancer cell growth and death.
In the HL-60 cell line, Ant 4 induced a signiﬁcant cytotoxic
response after 24 h exposure. Given such a cytotoxic response, it
was important to distinguish whether this was due to apoptotic or
necrotic causes. The DAPI-staining results demonstrated that the
HL-60 cell line displayed characteristic morphological features
of apoptosis after Ant 4 exposure. Induction of apoptosis is the
favoured cell-death pathway for any effective chemotherapeutic
drugbecauseapoptosisoccurswithoutinvolvementofanimmune
response. In fact, this result compares favourably with the
established chemotherapeutic agent etoposide, a potent inducer
of apoptosis and known inhibitor of topoisomerase II [17].
Thisﬁndingisalsoinkeepingwithdatapublishedonanotherof
the conjugates, Ant 4,4 [19,30]. This compound has been shown
to induce an accumulation of cells in the G0/G1- phase of the cell
cycle in both the B16 murine melanoma [24] and the HL-60 [30]
cell lines. We also demonstrated a signiﬁcant increase in the G0
population after 48 h exposure to Ant 4. Furthermore, Ant 4,4 has
been shown to cause a loss in mitochondrial membrane potential
and subsequent release of cytochrome c in the HL-60 cell line
[30], indicating that apoptosis is likely to be occurring via the
mitochondrial-dependent pathway.
Our novel ﬁnding of oxidative stress occurring provides a
possible mechanism for the triggering of apoptosis via the
mitochondrial pathway. In cells, glutathione functions to protect
cells from potentially damaging cellular stresses caused by
electrophilic compounds such as ROS (reactive oxygen species).
Therefore glutathione depletion acts as a measure of cellular
stress. Indeed, ROS have been implicated in apoptotic cell death
with mitochondria-generated ROS playing an important role in
the release of cytochrome c and other pro-apoptotic proteins
which trigger caspase activation and apoptosis [31]. Furthermore,
we also demonstrated that these compounds induce signiﬁcant
DNA damage, another well known signal for activation of the
mitochondrial pathway and a well known response to oxidative
stress.
In summary, the overall aim of the present study was to
investigate the potential of Ant 4 as a paradigm for the delivery
of cytotoxic substances via the PTS. Most excitingly, we have
demonstrated that these conjugates seem to have additional
effects over and above their original design (delivery) by also
depleting intracellular polyamines. In addition, the triggering
of apoptotic pathways, oxidative stress and DNA damage are
importantmechanismsofactionforthesecompounds.Finally,we
showed the successful utilization of the PTS for the ﬁrst time in
human cancer cells by one of these conjugates. Taken together
the ﬁndings of the present study demonstrate great promise
for the delivery of cytotoxic agents via the PTS.
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